As humans, we inherently appreciate higher levels of productivity—and that’s true regardless of whether we’re at home, working in the lab or taking part in a trial. Ticking a task off our to-do list results in the release of dopamine into our nervous system, learning a new skill creates a sense of growth and getting into a ‘flow state’ at work helps maintain healthy emotional regulation. When things are moving along well, we just know.
Life Science R&D is complex—and the stakes tend to be high. So, how can we reduce complication and encourage that all-important productivity? That’s where Human-centered Design (HCD) comes in.
Human-centered Design is an approach to designing services, products and experiences that involves the human perspective in all steps of the problem-solving process. In the Life Science arena, the results of HCD can be a return on investment through executive command and control of trial operations, faster recruitment, more trials completed and more empowered researchers.
Organizations like MediRedi—in partnership with frog—are using human insights to build digital technologies that reduce appointment wait times and connect patients with healthcare professionals from the comfort of their own home. Back in February 2020, frog partnered with HealthHero to launch a virtual primary care venture to bring together the convenience of digital delivery with the expertise of human clinicians, this business has grown to serve over 30 million patients across Europe.
There’s an opportunity to streamline the complexity of R&D to make the process of drug discovery and clinical trials faster, simpler, more productive and more satisfying through HCD.
Clinical trials are difficult to manage and administer due to the complexity of communication between different stakeholders. Complex data collection needs, regulatory and compliance and a requirement to keep patients engaged in trials means that often we look to technology to solve the problems.
What if you could create conditions that minimize waste, redundancy and white space during trials, whilst also improving the patient and investigator experience?
By examining and rethinking trials at a systems level, HCD simplifies the whole journey for administrators and patients: reducing unnecessary steps, managing live data and documents, supporting adherence and enabling confident cross-stakeholder decision-making.
With often limited numbers of eligible candidates, it can be a challenge to identify a suitable and diverse population of patients and then convert them into trial participants. Limited tools and resources often make it hard to connect with patients in way that sets expectations clearly.
What if you could quickly and easily recruit the right patients, for the right trial and reduce trial lengths or lead times?
HCD enables the identification of potential barriers for both patients and trial sites and thus opportunities to overcome them. In doing so, it’s possible to create services or experiences that bring both parties together.
Machine learning models and analytics software are increasingly being used across research; however, this requires jumping between different tools and often require deep data science knowledge with time spent coding and analyzing data.
What if you could streamline the connective tissue in research without jumping between different systems?
HCD has enabled familiar and intuitive interfaces to be developed that allow Research professionals to engage and utilize this groundbreaking technology across their organizations.
Innovation in Life Science R&D is crucial to success. By considering human needs alongside business goals and technical feasibility during drug discovery and clinical trials, HCD can reduce complexity and increase the productivity of those involved.